OpenVSafe by OpenVAERS
Search V-safe

9YD-23417-22601

3 vaccinations 3 coded responses 16 check-ins 3 free-text entries 0 call cases
Sex
Female
Age at first dose
21-25
ZIP prefix
744 / OK
Registered
2021-06-28
Relationship
Self
Race
American Indian or Alaska Native
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-06-28
    Registered in v-safe
  2. 2021-06-28
    Dose 1 — Pfizer-BioNTech
  3. 2021-06-28
    Health check-in — day 0, dose 1
    Feeling: Fair · None
    Adult check-in
  4. 2021-06-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-06-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  6. 2021-07-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-07-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-07-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-07-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-07-07
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-07-12
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-07-19
    Dose 2 — Pfizer-BioNTech
  13. 2021-07-19
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  14. 2021-07-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache
    Adult check-in
  15. 2021-07-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-07-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-10-18
    Survey response — 3 months, dose 2
    MedDRA: Dizziness, Headache — Feeling: Fair
    Free text: Dizziness, headaches.
    MedDRA releases: 2024-11 · check-in free text available
  18. 2021-12-13
    Dose 3 — Pfizer-BioNTech
    Co-administered: Flu
  19. 2022-01-05
    Survey response — day 21, dose 3
    MedDRA: Chills, Injection site pain, Otitis media, Pain, Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend school
    Free text: Arm sorness around injection site. Body aches. Chills. Upper respiratory infection, middle ear infection.
    MedDRA releases: 2024-11 · check-in free text available
  20. 2022-12-13
    Survey response — 12 months, dose 3
    MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Excessive fatigue.
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-06-28Pfizer-BioNTech No
22021-07-19Pfizer-BioNTech No
32021-12-13Pfizer-BioNTech Flu

Free text

Release 10 — 3 months, dose 2

2021-10-18

Symptoms: Dizziness, headaches.

Release 10 — day 21, dose 3

2022-01-05

Symptoms: Arm sorness around injection site. Body aches. Chills. Upper respiratory infection, middle ear infection.

Release 12 — 12 months, dose 3

2022-12-13

Symptoms: Excessive fatigue.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDChills · · ✓
SDDizziness · · ✓
SDFatigue · · ✓
SDHeadache · · ✓
SDInjection site pain · · ✓
SDOtitis media · · ✓
SDPain · · ✓
SDUpper respiratory tract infection · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release